+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Adenosine Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cushing Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cushing Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Polycystic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
REM Poisoning - Pipeline Insight, 2025 - Product Thumbnail Image

REM Poisoning - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2025 - Product Thumbnail Image

Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis Type I- Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis Type I- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cystic Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Huntington's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Huntington's Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Pneumococcal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Tendinopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Tendinopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hemophilia- Pipeline Insight, 2025 - Product Thumbnail Image

Hemophilia- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Type 1 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 1 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Graves' Orbitopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Orbitopathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2025 - Product Thumbnail Image

Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Rhinitis - Pipeline Insight, 2025 - Product Thumbnail Image

Rhinitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more